Skip to main content
Loading

Spotlight Presentation: Analytical Characterization of Oligonucleotides

30 Apr 2026
Novel Modalities & Discovery Drug Delivery CMC & Process Development Quality Control
Spotlight Presentation: Analytical Characterization of Oligonucleotides

Strategic application of advanced analytical techniques can help improve selection of candidates and guide development decisions, leading to a greater number of safer, more efficacious therapies successfully completing development and entering the market. ProtaGene offers a comprehensive suite of high-resolution analytical platforms for characterizing oligonucleotides, providing insights into their identity, purity, sequence, and structural modifications.

Industry Expert
Vanessa Gill, Director of Analytical Development and CMC - ProtaGene